Skip to main content
. 2009 Jul-Aug;2(3):172–175. doi: 10.4161/oxim.2.3.8482

Figure 1.

Figure 1

Effects of glucosamine on endothelial VCAM-1 and ICAM-1 expression. (A) Immunoblotting demonstrates that treatment of HUVECs with glucosamine (0.1 or 0.5 mmol/L, 5 days) had no effects on VCAM-1, but reduced ICAM-1 protein expression in response to TNFα (1 ng/ml, 24 hours, n = 3). (B) Quantification of the above results. *p < 0.05 vs. TNFα alone.